Search

Author/Creator Rodriguez, Claudio E

1. 044 Durable clinical efficacy of alemtuzumab in patients with active rrms in the absence of continuous treatment: 7-year follow-up of CARE-MS I patients (Topaz Study). Issue 6 (24th May 2018)

Authors:
McCombe, Pamela; Boyko, Alexey N; DeSeze, Jérôme; Hartung, Hans-Peter; Havrdova, Eva; Inshasi, Jihad Said; Montalban, Xavier; Pozzilli, Carlo; Selmaj, Krzysztof W; Vermersch, Patrick; Melanson, Maria; Daizadeh, Nadia; Rodriguez, Claudio E; Wijmeersch, Bart Van
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 89:Issue 6(2018)
Page Start:
A18
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies. (December 2020)

Authors:
Comi, Giancarlo; Alroughani, Raed; Boster, Aaron L; Bass, Ann D; Berkovich, Regina; Fernández, Óscar; Kim, Ho Jin; Limmroth, Volker; Lycke, Jan; Macdonell, Richard AL; Sharrack, Basil; Singer, Barry A; Vermersch, Patrick; Wiendl, Heinz; Ziemssen, Tjalf; Jacobs, Alan; Daizadeh, Nadia; Rodriguez, C...
Other Names:
Baker Darren P. non-byline-author.; Bueno Ericka M. non-byline-author.; Mitchell Colin non-byline-author.; Orndorff Rebecca L. non-byline-author.; Zediak Valerie P. non-byline-author.
Journal:
Multiple sclerosis
Issue:
Volume 26:Number 14(2020)
Page Start:
1866
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management. (January 2020)

Authors:
Cuker, Adam; Bass, Ann D; Nadj, Congor; Agius, Mark A; Steingo, Brian; Selmaj, Krzysztof W; Thoits, Timothy; Guerreiro, Alexandre; Van Wijmeersch, Bart; Ziemssen, Tjalf; Meuth, Sven G; LaGanke, Christopher C; Thangavelu, Karthinathan; Rodriguez, Claudio E; Baker, Darren P; Margolin, David H; Jann...
Journal:
Multiple sclerosis
Issue:
Volume 26:Number 1(2020)
Page Start:
48
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosis. (August 2019)

Authors:
Phelps, Richard; Winston, Jonathan A; Wynn, Daniel; Habek, Mario; Hartung, Hans-Peter; Havrdová, Eva Kubala; Markowitz, Glen S; Margolin, David H; Rodriguez, Claudio E; Baker, Darren P; Coles, Alasdair J
Journal:
Multiple sclerosis
Issue:
Volume 25:Number 9(2019)
Page Start:
1273
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗